Goutam Chowdhury Selected Research

Fluid Therapy (Oral Rehydration Therapy)

4/2013

Isolation and characterization of pandemic and nonpandemic strains of Vibrio parahaemolyticus from an outbreak of diarrhea in North 24 Parganas, West Bengal, India.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Goutam Chowdhury Research Topics

Disease

9	Neoplasms (Cancer) 04/2021 - 09/2003
8	Cholera 01/2021 - 08/2010
3	Diarrhea 01/2022 - 04/2013
3	Hypoxia (Hypoxemia) 01/2012 - 09/2003
2	Triple Negative Breast Neoplasms 04/2021 - 01/2021
2	Infections 12/2019 - 09/2013
2	Breast Neoplasms (Breast Cancer) 10/2019 - 09/2018
2	Multiple Myeloma 01/2017 - 01/2014
2	Leprosy (Hansen's Disease) 01/2017 - 01/2014
1	Drug-Related Side Effects and Adverse Reactions 01/2021
1	Hemolysis 01/2021
1	Carcinogenesis 01/2021
1	COVID-19 10/2020
1	Inflammation (Inflammations) 10/2020
1	Morning Sickness 01/2017
1	Enterobacteriaceae Infections 10/2016
1	Parkinson Disease (Parkinson's Disease) 02/2013
1	Colorectal Neoplasms (Colorectal Cancer) 01/2012

Drug/Important Bio-Agent (IBA)

6	Pharmaceutical PreparationsIBA 04/2021 - 09/2003
5	DNA (Deoxyribonucleic Acid)IBA 10/2020 - 09/2003
4	Tirapazamine (SR 4233)IBA 01/2012 - 09/2003
3	VaccinesIBA 01/2022 - 08/2010
3	Cholera ToxinIBA 01/2021 - 08/2010
3	Oxygen (Dioxygen)IBA 01/2012 - 11/2004
2	SurvivinIBA 04/2021 - 09/2018
2	Hemolysin Proteins (Hemolysins)IBA 01/2021 - 04/2013
2	Proteins (Proteins, Gene)FDA Link 09/2018 - 10/2016
2	glutarimideIBA 01/2017 - 01/2014
2	AntiemeticsIBA 01/2017 - 01/2014
2	Hypnotics and Sedatives (Sedatives)IBA 01/2017 - 01/2014
2	Thalidomide (Thalomid)FDA Link 01/2017 - 01/2014
2	Cholera Vaccines FDA Link 01/2014 - 08/2010
2	Antineoplastic Agents (Antineoplastics)IBA 01/2012 - 10/2007
1	ProteomeIBA 01/2021
1	thermostable direct hemolysinIBA 01/2021
1	AshwagandhaIBA 01/2021
1	Virulence Factors (Pathogenicity Factors)IBA 01/2021
1	Peroxynitrous Acid (Peroxynitrite)IBA 10/2020
1	Glutathione (Reduced Glutathione)IBA 10/2020
1	Sulfhydryl Compounds (Thiols)IBA 10/2020
1	Oxidants (Oxidizing Agents)IBA 10/2020
1	SolutionsIBA 08/2020
1	Azithromycin (Zithromax)FDA LinkGeneric 12/2019
1	Epidermal Growth Factor (EGF)IBA 10/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	sepantroniumIBA 09/2018
1	Biomarkers (Surrogate Marker)IBA 09/2018
1	Drug CombinationsIBA 01/2018
1	Peptide Hydrolases (Proteases)FDA Link 10/2016
1	Carbapenems (Carbapenem Antibiotics)IBA 10/2016
1	Chemotactic FactorsIBA 09/2013
1	Opioid Analgesics (Opioids)IBA 02/2013
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 02/2013
1	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 02/2013
1	myxinIBA 01/2012
1	Cyclic N-Oxides (Oxides, Cyclic N)IBA 01/2012
1	Anti-Infective Agents (Microbicides)IBA 08/2011
1	ABO Blood-Group SystemIBA 08/2010
1	Blood Group Antigens (Blood Groups)IBA 08/2010
1	Hydroxyl RadicalIBA 10/2007
1	Cytotoxins (Cytolysins)IBA 10/2007
1	3-amino-1,2,4-benzotriazineIBA 10/2007
1	3-amino-2-quinoxalinecarbonitrile 1,4-di-N-oxideIBA 11/2004
1	3-amino-2-quinoxalinecarbonitrileIBA 11/2004
1	EnzymesIBA 11/2004

Therapy/Procedure

2	Therapeutics 01/2021 - 10/2019
1	Drug Therapy (Chemotherapy) 01/2021
1	Combination Drug Therapy (Combination Chemotherapy) 01/2021
1	Fluid Therapy (Oral Rehydration Therapy) 04/2013